China's WHO rep. lauds approval of Sinopharm's jab

Sunday, 09. May 2021 13:27

World Health Organization's (WHO) decision to approve the COVID-19 vaccine developed by China National Pharmaceutical Group Corporation, better known as Sinopharm, proves that the jab is efficient and safe to use, Beijing's WHO representative Dr. Gauden Galea stated on Sunday.

"We look forward to such recognition of more Chinese-produced vaccines in the future, and not only for COVID-19," Galea said to the press, as translated by Xinhua.

The WHO said on Friday that Sinopharm's coronavirus vaccine is safe to use in the population aged 18 and older.

Related Links: 
Breaking the News / BU